Lung Adenocarcinoma
Treatment Options
If you have lung adenocarcinoma, call us. We can help you review the pathology, stage, biomarker report and options that are available.
The molecular profile can be as important as the stage in advanced lung adenocarcinoma. The complete report deserves careful review.
Call 1.800.923.7878The introductory call with our Patient Care Team is free. Medical recommendations require a physician consultation.
Talk With Our Lung Adenocarcinoma Team
Tell us what you are facing. Our Patient Care Team will follow up personally, explain the consultation process and help you understand the next step. The introductory call is free.
The diagnosis should connect pathology, stage and tumor biology
Lung adenocarcinoma is a subtype of non-small cell lung cancer. It often begins in the outer lung and can occur in people with or without a smoking history. Treatment depends on whether the tumor is localized, involves regional lymph nodes or has spread, and whether testing identifies a targetable molecular change.
Confirm what was sampled and how far disease extends
Adenocarcinoma can be diagnosed from a lung biopsy, lymph node, fluid or metastatic site. The report should be interpreted with CT, PET, brain imaging when appropriate and surgical findings. A small sample may establish the diagnosis but leave limited tissue for molecular testing.
- Primary tumor location and size
- Mediastinal and other lymph nodes
- Distant sites, including brain and bone
- Whether surgery is technically possible
- Biopsy source and tissue adequacy
- Complete molecular and PD-L1 results
Broad biomarker testing can change first-line treatment in advanced disease
Testing can identify molecular alterations for which targeted therapies may be available in the correct setting. The complete report, not only a short portal message, should be reviewed. PD-L1 is a separate marker used in immunotherapy decisions.
Localized, Stage 3 and metastatic adenocarcinoma are not treated the same way
Localized
Surgery is central for many operable tumors. Focused radiation may be used when surgery is not appropriate. Postoperative treatment depends on stage, pathology and biomarkers.
Locally advanced
Stage 3 decisions may combine systemic treatment, radiation and sometimes surgery. Resectability and lymph-node pattern are important.
Metastatic
Targeted therapy, immunotherapy, chemotherapy or combinations may be considered. Brain and other symptomatic sites can require local treatment.
After progression
Updated tissue or blood testing can help identify resistance mechanisms or clinical-trial questions.
Bring the original reports, images and treatment timeline
- Pathology report
- CT, PET and brain MRI
- Full molecular report
- PD-L1 report
- Surgery or radiation summary
- Systemic treatment and response
- Current medicines and supplements
- Symptoms and goals
Continue with the part of the diagnosis that matters now
Talk with our Patient Care Team for free
If you are facing lung adenocarcinoma, call us. We can help you organize the diagnosis, reports and questions that deserve a closer review. The introductory call is free and does not obligate you to schedule a consultation.
Frequently asked questions
Is lung adenocarcinoma always caused by smoking?
No. Smoking is a major lung cancer risk factor, but adenocarcinoma can occur in people who have never smoked.
What biomarkers are tested?
The exact panel varies, but advanced NSCLC commonly requires broad molecular testing plus PD-L1. The oncology team should interpret the complete report.
Can targeted therapy cure metastatic adenocarcinoma?
Targeted therapies can produce meaningful disease control in appropriate molecular subtypes, but metastatic lung cancer is generally treated as a chronic serious disease rather than promised to be cured.
Sources and important context
- Non-Small Cell Lung Cancer Treatment (PDQ®)
- Small Cell Lung Cancer Treatment (PDQ®)
- Biomarker Testing for Cancer Treatment
- Finding Cancer Care and Seeking a Second Opinion
- Cancer Therapy Interactions With Foods and Dietary Supplements
Medical information disclaimer: This page is for education and does not diagnose lung cancer or recommend a treatment plan. Decisions require review of the exact pathology, stage, biomarkers, prior treatment, medicines, symptoms and overall health. Do not start, stop or replace cancer treatment based on website content.